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Abstract 
Background: Research on theory of mind (ToM) abilities in patients with bipolar disorder has yielded conflicting 
results. Meta-analyses point to a stable moderate impairment in remitted patients, but factors such as subsyndromal 
symptoms, illness severity, and deficits in basic neurocognitive functions might act as confounders. Also, differences 
in deficits depending on task area (cognitive or affective) or task modality (visual or verbal) have been observed. This 
study aimed to test the hypothesis that euthymic bipolar patients would perform more poorly than healthy subjects 
on visual cognitive and visual affective ToM tasks. Furthermore, we aimed to explore the relationship between ToM 
performance and basic neurocognitive functions, subsyndromal symptom severity, and illness burden. Twenty-nine 
clinically stable outpatients with bipolar disorder and 29 healthy comparison subjects completed a measure of visual 
cognitive ToM (Mental State Attribution Task, MSAT), a measure of visual affective ToM (Reading the Mind in the Eyes 
Test, RMET), and a battery of tests assessing neurocognitive functioning (attention, verbal memory, executive func-
tions, and intelligence).
Results: Patients did not differ significantly from healthy controls for the ToM tasks or any of the neurocognitive 
measures, suggesting a high level of neurocognitive functioning in the bipolar group. On average, patients were 
slower than controls to complete the ToM tasks. Within the bipolar group, ToM performance was moderately cor-
related with attention, verbal memory and reasoning abilities. Performance on the RMET was positively correlated 
with clinician-rated depressive symptoms with a small effect. Number of years of illness was weakly and negatively 
correlated with performance on the MSAT. Overall, no moderate or strong correlations were found between ToM per-
formance, subsyndromal depressive or manic symptoms, illness duration, and number of depressive or (hypo)manic 
episodes. Moderate correlations between ToM performance and age were found for patients but nor for controls.
Conclusions: Our findings suggest preserved visual cognitive and affective ToM abilities in euthymic bipolar patients 
characterized by a high level of neurocognitive functioning.
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Background
Theory of mind (ToM) is an aspect of social cognition 
that describes the ability to understand the feelings, 
thoughts and intentions of oneself and of others (Brüne 
2008). The term was originally introduced in 1978 by 
Premack and Woodruff (1978) in an article that discussed 
the ability of chimpanzees to infer mental states that are 
not directly observable (for example, intentions, knowl-
edge or beliefs) and that can serve to predict the behavior 
of others. The article sparked a wave of research on ToM 
that has been increasing ever since. As Schaafsma et al. 
(2015) point out, the original definition of ToM referred 
to a variety of processes which led to heterogeneity in the 
scientific methods approaching ToM. Thus, as research 
on the topic is growing, attempts to clarify the construct 
are advancing.
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In psychological terms, ToM has recently been 
described as dual-process schemes that distinguish either 
between mental state reasoning (social-cognitive pro-
cesses) and mental state decoding (social-perceptual pro-
cesses) (Samamé et  al. 2012) or between cognitive and 
affective ToM (Shamay-Tsoory et al. 2007). The identifi-
cation of particular ToM processes is directly related to 
the interpretation of different tasks designed to measure 
ToM abilities. Tasks that request subjects to understand 
the beliefs or false beliefs of other persons to detect hid-
den intentions, indirect meaning, or inappropriate social 
communication are assumed to account for cognitive 
ToM or mental state reasoning. On the other hand, tasks 
that demand of subjects to infer the feelings or affective 
mental states of others are regarded as measures to assess 
affective ToM and also mental state decoding abilities if 
visual information such as facial expressions needs to be 
decoded. These dual-process schemes are supported by 
evidence from imaging studies that have reported task-
specific differences in brain activation patterns (Kalbe 
et al. 2010; Schurz et al. 2014; Shamay-Tsoory and Aha-
ron-Peretz 2007).
The ability to understand the mental or affective states 
of others has been found to be impaired in some devel-
opmental and mental disorders. ToM deficits have con-
sistently been observed in patients with autism spectrum 
disorders (Frith 2012) and schizophrenia (Savla et  al. 
2013). Bipolar disorder (BD) is often discussed in relation 
to schizophrenia and much research is done comparing 
the two conditions. In BD, ToM deficits have been less 
consistently shown than in schizophrenia (Mitchell and 
Young 2016). Studies on ToM in BD vary widely in how 
ToM has been operationalized, hence rendering the col-
lective findings difficult to interpret. This may be related 
to possible moderating variables such as subsyndro-
mal symptom severity, indicators of illness burden, and 
basic neurocognitive functions not always being taken 
into account. Indeed, the association between these fac-
tors and ToM abilities has, to date, not been explicitly 
clarified.
Recently, two task-specific meta-analyses were con-
ducted to synthesize the heterogeneous results yielded 
so far in this field. A meta-analysis by Samamé et  al. 
(2015) reported small-to-medium effect sizes for tasks 
measuring cognitive ToM and small effect sizes for tasks 
measuring affective ToM in favor of healthy controls 
(HCs) versus euthymic bipolar patients (eBPs). Based on 
a slightly extended data pool, Bora et  al. (2016) specifi-
cally investigated the relationship between ToM deficits 
and mood state. Pooling all studies irrespective of task 
modality or content, they found stable moderate effects 
in strictly euthymic BD samples, as well as in subsyndro-
mal samples, favoring HCs. In acute BD samples, a strong 
effect favoring HCs was found, which was significantly 
more severe than the effect found for remitted or subsyn-
dromal samples. ToM deficits seem to be more reliably 
present in acute BPs than in strictly euthymic samples 
(Kerr et al. 2003; Ioannidi et al. 2015). The first prospec-
tive study to assess the effect of remission on ToM per-
formance in BPs has found patients to recover nearly all 
of their neurocognitive and social-cognitive abilities dur-
ing remission, with the exception of performance on the 
Faux Pas Task, verbal memory, and visuospatial working 
memory (Ioannidi et  al. 2015). In the meta-regression 
analyses performed by Bora et al. (2016), clinician-rated 
manic symptoms were significantly related to the severity 
of ToM impairment, but not clinician-rated depressive 
symptoms. No significant effects of gender, age, educa-
tion, illness duration, or age at illness onset on ToM per-
formance in remitted or subsyndromal BPs were found. 
In contrast, global cognitive impairment was significantly 
associated with ToM deficits in the whole sample and in 
remitted and subsyndromal samples only. In previous 
studies, ToM performance in bipolar-only and mixed 
samples (i.e., with both eBPs and HCs) has been found to 
correlate with general intellectual functioning, attention, 
memory and executive functions (Ioannidi et  al. 2015; 
Bora et al. 2005; Purcell et al. 2013; Wolf et al. 2010; Mar-
tino et al. 2011; Donohoe et al. 2012). Performing a path 
analysis, Van Rheenen et al. (2014) found that neurocog-
nition (a composite score) directly predicted variance in 
ToM performance, concluding that neurocognition and 
social cognition are related in BD. As ToM performance 
seems to correlate with a variety of neurocognitive func-
tions, it should also be considered that BD may be char-
acterized by consistent deficits across almost all basic 
neurocognitive domains (for a comprehensive review of 
recent data, see Fountoulakis (2015)). Deficits have most 
consistently been shown for executive functions (par-
ticularly response inhibition) and verbal memory, both 
of which have been discussed as possible cognitive endo-
phenotypes for BD (Fountoulakis 2015).
Few studies, so far, have examined secondary meas-
ures of ToM, such as reaction times or task completion 
duration, and findings have conflicted. Two studies have 
reported eBPs to perform more slowly than HCs on an 
affective ToM task and a cognitive ToM task, respec-
tively, while accuracy was the same for both groups in 
both studies (Kim et al. 2009; Olley et al. 2005). In con-
trast, another study found eBPs to show faster reaction 
times than HCs in a computerized affective ToM task 
with accuracy again being consistent (Purcell et al. 2013). 
In that study, quicker responding was related to lower life 
functioning at a 1-year follow-up.
In the present study, we aimed to specifically investi-
gate visual cognitive and visual affective ToM abilities in 
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eBPs and to explore their relationship with basic neuro-
cognitive functions, subsyndromal symptom severity, and 
indicators of illness burden. As primary outcome meas-
ures, we chose the Mental State Attribution Task (MSAT; 
Brüne 2003) to measure visual cognitive ToM, and the 
Reading the Mind in the Eyes Test (RMET; Baron-Cohen 
et  al. 2001) to measure visual affective ToM. Next, we 
were interested in the difference of time taken to com-
plete the ToM tasks in patients versus controls.
We hypothesized that euthymic bipolar patients would 
perform worse than healthy controls on both the MSAT 
and the RMET. Further, we hypothesized that patients 
would differ in the time they would take to complete the 
tasks compared to the controls, but made no predictions 
about the direction of the effect. Correlations between 
variables were tested exploratively.
Methods
Design and participants
The study employed a cross-sectional correlational design 
to describe the abilities of euthymic bipolar patients rela-
tive to healthy controls in visual cognitive and affective 
ToM and to examine the relationship between ToM per-
formance and neurocognitive functioning, subsyndro-
mal symptom severity, and illness burden. Patients were 
recruited at the outpatient clinic of the Department of 
Psychiatry and Psychotherapy at Charité University Hos-
pital Berlin, Campus Mitte. Patients had to be euthymic 
for a minimum of 6 weeks prior to testing as determined 
by a score ≤9 on the 21-items-version of the Hamilton 
Depression Rating Scale (HAMD; Hamilton 1960) and 
a score ≤12 on the Young Mania Rating Scale (YMRS; 
Young et  al. 1978). Further, patients’ mood-stabilizer 
intake had to be stable for at least the six preceding 
weeks. Exclusion criteria included a history of substance 
abuse or electroconvulsive therapy in the last 6 months, 
and a previous diagnosis of schizoaffective disorder, 
schizophrenia, antisocial personality disorder, demen-
tia, mild cognitive impairment or mild intellectual dis-
ability according to ICD-10 (World Health Organisation 
2016). Patients were not preselected on the basis of any 
neurocognitive measure before entering the study. Paral-
lel to the study, patients were invited to participate in an 
8-week metacognitive training program after complet-
ing the study measures. Patients did not receive finan-
cial compensation for this. Out of 72 subjects screened, 
34 patients were included in the present study. A total of 
five patients were excluded from analysis post hoc: Four 
patients revealed to meet exclusion criteria (e.g., cur-
rent alcohol abuse, mild intellectual disability and acute 
depression), while one patient refused to participate in 
the cognitive ToM task and was excluded due to miss-
ing data. The final clinical sample included 29 individuals 
diagnosed with bipolar disorder type I or II according to 
ICD-10 criteria.
The control sample was recruited by online advertise-
ment or via contacts of the researchers. Exclusion criteria 
included a history of any psychiatric disorder as assessed 
via the Mini International Neuropsychiatric Interview 
(MINI; Sheehan et  al. 1998), self-reported severe physi-
cal health problems, and first-degree relatives with a psy-
chiatric condition. Thirty-four subjects were included 
in the study. Five participants were excluded post hoc 
from analysis, because they had a history of an affective 
disorder or substance abuse. The final sample comprised 
29 healthy participants. The study was approved by the 




In patients, current depressive symptoms were measured 
via the HAMD and the Beck Depression Inventory (BDI; 
Beck et al. 1961) Manic symptoms were assessed with the 
YMRS and the Altman Self-Rating Mania Scale (ASRM; 
Altman et al. 1997). Also, duration of illness and number 
of previous depressive and (hypo)manic episodes were 
recorded as demographics. Controls were administered 
the MINI, the BDI, and the Brief Symptom Inventory 
(BSI; Franke 2000).
Theory of mind tasks
Visual cognitive ToM was assessed with the Mental State 
Attribution Task (MSAT) developed by Brüne (2003). 
This task consists of six ToM cartoon stories, each com-
prising four picture cards. For each story, the four cards 
were placed face down in front of the participants in ran-
dom order. The participants were then requested to turn 
them over and organize the cards into a logical sequence. 
The time taken for sequencing was noted. If the cards 
were sequenced incorrectly, the experimenter placed 
them in the right order. Next, the participants were asked 
questions about the mental states of the characters in the 
cartoon. To answer the questions correctly, the partici-
pants had to understand characters’ first-order, second-
order, or third-order true or false beliefs, reciprocity, 
deception and cheating intentions. Two questions were 
“reality” questions that did not require inferences about 
mental states but rather merely the detection of facts 
from the story that were visually comprehendible. Two of 
the picture stories as well as the method of rating were 
adapted from Langdon et al. (1997). The correct sequenc-
ing of the first and last cards was given two points, while 
the correct sequencing of the second and third card was 
awarded one point. Each correctly answered question 
was awarded one point. A total score comprising the 
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sequencing-accuracy score and the correctly answered 
questions was computed (with a maximum of 59 points). 
Two practice samples depicting “reality” (i.e., non-ToM) 
stories taken from Langdon et  al. (1997) were adminis-
tered before the main task. The variables of interest were 
the total score and the total time taken for the sequenc-
ing of the six cartoons (measured in seconds).
Visual affective ToM was measured with the Read-
ing the Mind in the Eyes Test (RMET; German version 
by Bölte (2005)). The RMET consists of a series of 36 
sheets with a pair of eyes printed in the middle of each 
sheet. Each pair of eyes is presented with four words that 
describe emotions or affectively valenced states of mind 
(e.g., “anxious” or “confused”). From an answer sheet, 
the participants were instructed to choose the word that 
best described what the person in the picture was feeling, 
thinking or trying to express. No time restrictions were 
imposed, but participants were informed that they were 
being timed. A maximum of 36 points could be achieved. 
The variables of interest were the total score and the time 
taken to complete the task measured in minutes.
Neuropsychological measures
The neuropsychological assessment comprised 17 tests 
measuring selected facets of attention, memory, execu-
tive functions, and general cognitive ability. Three 
subtests of the computer-based Test of Attentional Per-
formance (TAP; Zimmermann and Fimm 1994) were 
administered to measure tonic and phasic alertness 
(subtest “Alertness”, reaction time), visual and auditory 
divided attention (subtest “Divided Attention”, reaction 
time), general divided attention (subtest “Divided Atten-
tion”, number of lapses), and selective attention (sub-
test “Go/No-go”, reaction time). Auditory short-term 
memory and auditory working memory were measured 
using the Digit Span Forward and Digit Span Backward 
subtests of the revised Wechsler Memory Scale (WMS-
R; Härting et al. 2000). The Verbal Learning and Memory 
Test (VLMT; Helmstaedter et al. 2001) was used to assess 
verbal learning, verbal consolidation and verbal recog-
nition. Cognitive inhibition was measured with the Go/
No-go subtest of the TAP (number of errors) and with 
the Stroop Colour–Word Task (Bäumler 1985). Phone-
mic and semantic verbal fluency were measured with the 
subscales “S-words” and “animal names” of the Regens-
burger Wortflüssigkeits-Test (RWT; Aschenbrenner et al. 
2000). The third subtest of the German intelligence test 
battery Leistungsprüfsystem (LPS3; Horn 1983), a fig-
ure sequence task, was used to assess reasoning abili-
ties. Verbal intelligence was measured with version B of 
the Mehrfachwahl-Wortschatz-Intelligenztest (MWTB; 
Lehrl 2005) which is similar to the Spot-the-Word Test 
(Baddeley et al. 1993).
All tests and interviews were conducted by trained 
postgraduate psychology or medical students.
Statistical analyses
Data were analyzed with RStudio Desktop version 
0.99.484 (R Core Team 2013). To determine group differ-
ences between eBPs and HCs, several statistical proce-
dures were employed depending on the scale of variables 
and their distributions. Group comparisons between cat-
egorical variables were performed using the Chi-squared 
test. The distributional properties of each continuous 
variable were graphically explored using histograms and 
box plots. For continuous variables, data outliers were 
identified and the assumptions of normality were tested 
using the Shapiro–Wilk test for each group level sepa-
rately. Group differences on variables that were normally 
distributed and did not contain outliers were analyzed 
using independent samples t tests. Welch’s adjustment 
was set as the default. Differences on variables that were 
not normally distributed or contained outliers in one or 
both of the groups were analyzed with the Yuen–Welch 
t test (Yuen 1974), a robust test to compare independ-
ent means that employs trimmed population means and 
Winsorized variances in combination with Welch’s two-
sample test. The level of trimming in our study was set to 
20 %.
Two measures of effect size were computed for group 
comparisons on neurocognitive and ToM variables: 
Cohen’s d, and the explanatory measure of effect size ξ 
(xi) proposed by Wilcox and Tian (2011). Xi is a robust 
measure of effect size that allows for heteroscedastic-
ity. Cohen’s d is based on the mean and variance, which 
means that it is not robust when the assumptions of nor-
mality and homoscedasticity are not met. Conventionally, 
d = 0.2, 0.5 and 0.8, as well as ξ = 0.15, 0.35 and 0.50 are 
considered small, moderate and large effect sizes (Cohen 
1988; Wilcox 2012). To facilitate the comparability of our 
results to other studies, we decided to report results of 
Welch’s t test and Cohen’s d also for variables that did 
not fulfill the aforementioned assumptions. Nonetheless, 
inferences were based on robust tests for variables that 
presented non-normal distributions or outliers.
Kendall’s tau correlation coefficient, τ, was calculated 
as a robust measure to determine associations between 
variables. Conventionally, correlations around 0.10, 0.30 
and 0.50 are considered weak, moderate and large effect 
sizes, respectively (Cohen 1988). Furthermore, a mini-
mum correlation of 0.20 is recommended as a marker of 
practical significance (Ferguson 2009); henceforth, only 
correlations above that level are reported and discussed.
The alpha-level was set to 0.05 for all statistical tests. 
When multiple tests were conducted, Bonferroni-
adjusted alpha levels were used for hypothesis testing.
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Results
Demographic and clinical features
Patients and controls were matched for gender and years 
of education. On average, patients were older than con-
trols and this difference was statistically significant. 
Demographic and clinical features of the samples are dis-
played in Table 1.
Theory of mind performance
It was hypothesized that euthymic bipolar patients would 
perform worse than healthy controls on the MSAT and 
the RMET. One-tailed t tests were performed to test 
these predictions. Furthermore, it was hypothesized that 
eBPs and HCs would differ in their time taken to com-
plete the sequencing part of the MSAT and to complete 
the RMET. These hypotheses were tested with two-tailed 
t tests. In this group of variables, four comparisons per 
variable were computed and the level of significance was 
Bonferroni-adjusted and set to α = .013. Contrary to our 
hypotheses, all group differences were statistically non-
significant. On average, HCs performed better than eBPs 
on the MSAT, with the group difference representing a 
small effect size. A small effect size favoring patients was 
found for RMET performance. An effect size in the small 
range was also found for visual cognitive ToM sequenc-
ing time, where patients were slower than HCs. Patients 
were also slower to complete the Eyes Test, with group 
differences indicating a large effect. On the MSAT, 31 % 
of patients and 34  % of controls achieved a score of 59 
(maximum) or 58 points, indicating a ceiling effect for 
that measure. Figures are presented in Table 2.
Neurocognitive functioning
As a total of 17 correlations were calculated, the alpha-
level for statistical significance was Bonferroni-adjusted 
and set to α =  .003. As evidence points to stable neuro-
cognitive deficits in bipolar patients, we hypothesized 
that eBPs would perform worse than HCs on our meas-
ures of neurocognition. One-tailed t tests were per-
formed to test these hypotheses.
All group differences were statistically nonsignificant. 
In terms of the effect sizes, no effects were observed for 
differences between eBPs and HCs in phasic alertness, 
visual divided attention, working memory, reasoning 
abilities and verbal intelligence. Small effect-sizes favor-
ing controls were observed for tonic attention, auditory 
divided attention, selective attention, verbal learning, ver-
bal consolidation, verbal recognition, cognitive inhibition 
Table 1 Participant characteristics
ty = t value based on Yuen–Welch test
a Variable is normally distributed
Measure Bipolar patients Healthy controls Statistics df p
n n
Agea, M (SD) 29 47.8 (13.6) 29 40.8 (12.7) t = 2.009 55.73 .049






Gender, male/female ratio 29 16/13 29 10/19 χ2 = 1.743 .187






ASRM score, M (SD) 29 2.3 (2.6)
HAMD score, M (SD) 29 5.7 (2.8)
YMRS score, M (SD) 29 1.5 (2.2)
Bipolar disorder type I, n (%) 29 15 (52)
History of psychotic symptoms, n (%) 29 10 (34)
Psychiatric medication, n (%) 29
 Mood stabilizers 29 (100)
 Antipsychotics 3 (10)
 Antidepressants 13 (45)
 Anxiolytics 3 (10)
 Hypnotics 1 (3)
Illness durationa in years, M (SD) 29 22.6 (11.2)
Number of depressive episodes, M (SD) 29 12.8 (7.5)
Number of (hypo)manic episodes, M (SD) 29 8.8 (6.4)
Page 6 of 11Haag et al. Int J Bipolar Disord  (2016) 4:20 
as measured by the Go/No-go error rate, and cognitive 
inhibition as measured by the Stroop Task. Effect sizes in 
the small range favoring patients were found for general 
divided attention, and short-term memory. Effect sizes in 
the medium range favoring controls were found for lexi-
cal and semantic verbal fluency. Figures are presented in 
Table 2.
Correlations
In the bipolar group, Kendall’s tau correlation coefficients 
were calculated as robust statistics to determine the asso-
ciations between ToM performance variables (MSAT 
and RMET sum scores) and neurocognitive measures (all 
measures displayed in Table 2), and between ToM perfor-
mance variables and clinical measures (BDI total score, 
Table 2 Group comparisons for ToM and neurocognition
RT reaction time (mean median reaction times)
a Variable is normally distributed
b No outliers in either group
Bipolar patients Healthy controls Statistics
n M (SD) n M (SD) t ty df p d ξ
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ASRM total score, HAMD total score, YMRS total score, 
years of illness duration, number of depressive episodes, 
and number of (hypo)manic episodes). For each ToM 
variable, 24 correlation coefficients were computed, and, 
the family-wise alpha-level was set to p = .002. In terms 
of effect sizes, weak negative correlations were observed 
between visual cognitive ToM performance and tonic 
alertness (rτ = −.20, p =  .135), visual divided attention 
(rτ = −.22, p = .10), general divided attention (rτ = −.23, 
p = .113), and verbal consolidation (rτ = −.21, p = .141). 
Moderate positive correlations were found between vis-
ual cognitive ToM performance and verbal recognition 
(rτ = .45, p = .002), reasoning abilities (rτ = .42, p = .003), 
and verbal learning (rτ = .45, p = .001), the latter reach-
ing statistical significance. All reported positive and neg-
ative correlations indicated that a higher performance in 
one test was associated with higher performance on the 
other tests.
Visual affective ToM performance showed a weak 
negative correlation with selective attention (rτ = −.23, 
p  =  .096), and a weak positive correlation with verbal 
learning (rτ =  .25, p =  .075). A moderate positive corre-
lation was found between RMET performance and ver-
bal recognition (rτ =  .35, p =  .016) and with reasoning 
abilities (rτ =  .30, p =  .032). A moderate negative corre-
lation was found between RMET performance and tonic 
alertness (rτ = −.38, p = .006), and with phasic alertness 
(rτ  =  −.34, p  =  .013). Again, all reported positive and 
negative correlations indicated that a higher performance 
in one test was correlated with a higher performance on 
others.
Concerning the clinical variables, a weak positive cor-
relation was observed between clinician-rated depressive 
symptoms (HAMD) and RMET performance (rτ  =  .21, 
p  =  .136), where having more symptoms was corre-
lated with a higher number of correctly answered items. 
Number of illness years was weakly and negatively cor-
related with the MSAT sum score (rτ = −.25, p =  .063), 
indicating a lower performance over the course of years 
living with the illness. No other correlations above 0.20 
were observed between clinical variables and cognitive or 
affective ToM performance.
As the groups were not matched for age, Kendall’s tau 
correlation coefficients were calculated between age and 
the primary outcome measures MSAT sum score and 
RMET sum score within each group separately. A total of 
two correlations were calculated per group; so, the alpha-
level for statistical significance was Bonferroni-adjusted 
and set to α =  .025. In the patient group, age was nega-
tively correlated in a statistically significant way with 
visual cognitive ToM performance (rτ = −.31, p = .023). 
The negative correlation found between age and visual 
affective ToM was also in the moderate range but did not 
reach statistical significance (rτ = −.30, p =  .031). Both 
correlations indicated a lower performance with increas-
ing age. In the group of HCs, age was not correlated with 
either variable.
Discussion
A recent meta-analyses indicates the occurrence of a 
ToM deficit in bipolar patients across all mood states, 
with remitted or subsyndromal patients showing stable 
modest deficits, albeit less severe than during acute epi-
sodes (Bora et  al. 2016). Nevertheless, the variability in 
effect sizes between studies is large and the role of possi-
ble confounding factors such as neurocognitive functions 
and clinical variables has not been established conclu-
sively. Also, differential patterns of impairment might 
exist depending on task area (cognitive or affective) and 
task modality (verbal or visual). In the present study, 
we aimed to exclusively examine the performance of 
euthymic bipolar patients in visual cognitive and affective 
theory of mind in comparison to healthy subjects, as defi-
cits in those domains have been less consistently shown 
for remitted than for acute patients (Kerr et  al. 2003; 
Ioannidi et  al. 2015; Olley et  al. 2005). Contrary to our 
hypotheses, patients did not differ in a statistically signifi-
cant way from controls on our measures of visual cogni-
tive and visual affective ToM. Also in disagreement with 
our hypotheses, we did not find statistically significant 
differences between patients and controls regarding their 
time taken to complete either of the ToM tasks. In terms 
of effect sizes, our findings were also below the effect 
sizes reported in recent meta-analyses. While Samamé 
et  al. (2015) have reported effect sizes in the small-to-
medium range for cognitive ToM, and Bora et al. (2016) 
have reported effect sizes in the moderate range pooling 
across ToM tasks, we observed only a small effect in favor 
of controls on the performance of our cognitive ToM 
task. On our visual affective ToM task, there was even a 
small effect favoring the performance of patients. With 
respect to ToM task completion time, we found controls 
to be faster than patients with a small effect size on the 
cognitive ToM task. A large effect in favor of controls was 
found for the time taken to complete the affective ToM 
task.
In direct comparison to studies that also used a car-
toon task to measure visual cognitive ToM, our find-
ing is in contrast with the results of the study by Wolf 
et  al. (2010) that found a statistically significant differ-
ence between patients and controls, with a large effect 
in favor of healthy participants. On the other hand, our 
results are in line with findings by Kerr et al. (2003) and 
Olley et  al. (2005) that reported similar performance 
for patients and controls. Importantly, patients in our 
study and in the study by Olley et  al. presented with a 
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high level of neurocognitive functioning, whereas they 
showed pronounced deficits in executive functioning 
relative to controls in the study by Wolf and colleagues. 
In our study, none of the group differences on neurocog-
nitive measures were statistically significant. Further, our 
effect sizes were on the lower edge of or below the effect 
sizes reported in the previous literature. Notably, we did 
not find the typically reported medium-to-large or large 
effect sizes in the domains of verbal memory and cogni-
tive inhibition, which are currently discussed as possible 
cognitive endophenotypes of BD (Fountoulakis 2015). 
Furthermore, the remitted group in the study by Wolf 
et  al. showed slightly elevated levels of subsyndromal 
symptoms; in particular a higher level of manic symp-
toms. In the meta-regression analysis performed by Bora 
et al. (2016), clinician-rated manic symptoms were signif-
icantly related to the severity of ToM deficits. Moreover, 
the patients in the study by Wolf et al. were remitted in 
the course of the last 4 weeks prior to testing, while they 
had to be remitted for at least 4  weeks in the study by 
Olley et al., and for at least 6 weeks in our study. It is pos-
sible that not only the decrease of symptoms, but also the 
time passed since remission is important for the recov-
ery of neurocognitive and social-cognitive abilities. In a 
longitudinal study by Volkert et al. (2016) that employed 
a within-subjects pre-post design, cognitive performance 
in bipolar patients had considerably improved after 
3 months of euthymia.
Our finding of patients performing in line with con-
trols on the RMET is in contrast with effect sizes in the 
small-to-medium range favoring controls reported for 
this visual affective ToM task in the abovementioned 
meta-analyses. Nonetheless, some studies that directly 
compared affective ToM and cognitive ToM in eBPs have 
found differential patterns of impairment, with affective 
ToM abilities being preserved or less affected than cog-
nitive ToM abilities (Samamé et  al. 2015; Montag et  al. 
2010; Barrera et  al. 2013; Shamay-Tsoory et  al. 2009). 
Furthermore, as with cognitive ToM, neurocognitive 
functioning seems to be related to affective ToM perfor-
mance, and this may, therefore, partly explain the diver-
sity of findings. This hypothesis is supported by evidence 
from a recent study that has suggested the existence of 
several neurocognitive subgroups within the population 
of bipolar patients (Burdick et al. 2014). Importantly, the 
group of patients, which was on the same level of neu-
rocognitive functioning as the HCs, outperformed the 
HCs on a measure of affective social cognition, while the 
other two patient subgroups performed worse than the 
controls on that measure. This finding suggests that in a 
subgroup of bipolar patients with preserved neurocog-
nitive functioning, affective ToM abilities might even be 
elevated compared to the general population.
Considering that we chose to measure cognitive and 
affective ToM abilities based on visual material, our find-
ings do correspond with results of the study by Olley 
et  al. (2005), where a ToM deficit was observed in the 
verbal cognitive ToM task, but not in the visual cogni-
tive ToM task. This pattern has also been found in unaf-
fected first-degree adult relatives (FDRs) of individuals 
with BD (Reynolds et  al. 2014), where FDRs performed 
worse than HCs on a cognitively demanding verbal ToM 
task, but showed no deficits on either the cognitive or 
affective visual ToM tasks. Thus, our results also sup-
port the hypothesis of these authors that ToM deficits 
in BD might represent a modality-specific disturbance, 
with visual social perceptual skills being preserved or less 
affected than verbal social cognitive skills.
Through the comparison of studies with diverging 
results on ToM in BD, it has become apparent that basic 
neurocognitive functioning might be decisive for ToM 
performance. In our study, only the correlation between 
performance on the MSAT and verbal learning reached 
statistical significance. Nonetheless, correlations between 
both ToM tasks and several measures of verbal memory, 
attention and reasoning were in the small-to-moderate 
range and could indicate existing relationships and prac-
tical significance.
Results concerning the effect of illness burden and sub-
syndromal symptoms on ToM abilities are more ambigu-
ous. In our sample, neither variables of illness burden nor 
measures of subsyndromal symptoms were significantly 
related to ToM performance. However, this finding might 
be due to the low level of current symptoms and the high 
level of neurocognitive functioning and ToM perfor-
mance in our sample. Interestingly, ToM performance 
was negatively correlated with age in the bipolar group 
but not in the control group. In the study by Wolf et al. 
(2010), age was also found to correlate negatively with 
performance on ToM tasks. An explanation for this find-
ing might be that age by itself represents an indicator of 
illness severity that bundles factors such as illness dura-
tion and number of episodes which might be related to 
a decline in cognitive abilities. Yet, there is also evidence 
pointing to a null relationship between age and ToM 
abilities and BPs (Donohoe et al. 2012; Inoue et al. 2004), 
and the effect we found could be spurious. In sum, the 
correlations reported in the current study are in line with 
the literature where the link between ToM performance 
and basic neurocognitive functions has more consist-
ently been emphasized over and above the relationship 
between ToM performance and clinical variables (Mitch-
ell and Young 2016; Bora et al. 2016).
Yet, neurocognitive functions themselves seem to be 
vulnerable to clinical variables which might, therefore, 
also be relevant for social cognition, albeit indirectly. 
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Preliminary findings indicate that illness severity fac-
tors such as age at illness onset, number of episodes 
(especially manic episodes) and absence of remission 
could be related to a progressive neurocognitive decline 
(Fountoulakis 2015). Similar findings have emerged from 
recent studies that have suggested the existence of several 
neurocognitive subgroups within the population of BPs 
(Burdick et al. 2014; Martino et al. 2014). In one of these 
studies, neurocognitive impairment was related to the 
total number of affective episodes (Burdick et  al. 2014). 
Another study showed a higher number of hospitaliza-
tions in the subgroup of cognitively impaired BPs com-
pared to the subgroup of cognitively preserved patients 
(Martino et al. 2014). In a study by Volkert et al. (2014), 
where BPs were divided into two subgroups accord-
ing to their neurocognitive performance, the group that 
showed deficits in at least one neurocognitive domain 
reported more sub-threshold depressive symptoms, 
more sleep disturbances, and, more often, a comorbid 
anxiety disorder compared to the group that was on the 
same level of neurocognitive functioning as HCs. Our 
sample of patients that did not show deficits in neuro-
cognitive and social-cognitive functioning might, thus, 
be interpreted as representing the subgroup of BPs with 
preserved neurocognitive functions. This sample compo-
sition might be due to our strict criteria of euthymia and 
time elapsed since remission, or due to effective prophy-
lactic treatment (Pfennig et al. 2014). What may be even 
more important than the clinical stability of our patients 
is their relatively high level of education: While there is 
no evidence to support this hypothesis to date, it is plau-
sible that education levels may be related to neurocogni-
tive performance.
In summary, our study supports the notion that vis-
ual cognitive and visual affective ToM abilities are not 
impaired in bipolar patients with a high level of neuro-
cognitive functioning. However, our results indicate that 
patients might take more time to complete ToM tasks 
which by itself could be relevant for psychosocial func-
tioning. It might be that not only the level of performance 
is relevant to social communication, but also the speed 
at which inferences about mental states can be drawn. 
Future studies are warranted to investigate the different 
facets of ToM abilities in neurocognitive subgroups of 
BD, and to identify factors associated with neurocogni-
tive and social-cognitive impairments in BD, e.g., clinical 
variables like single symptoms and recovery time. In view 
of the variability of findings reported across studies, it 
seems too early to draw conclusions about the stability of 
ToM deficits in BD.
Several limitations of our study have to be considered. 
First, as we only assessed measures of visual cognitive 
and affective ToM, no comparisons could be made with 
performance on measures of verbal cognitive and affec-
tive ToM. Furthermore, our measure of visual cognitive 
ToM showed a ceiling effect which might mean that the 
task was too easy to detect an effect. Further limitations 
to our study are the small sample size which is associ-
ated with low statistical power, and the possible influ-
ences of psychotropic medication on the performance of 
patients. Also, our patient sample was characterized by a 
higher level of neurocognitive functioning than is often 
reported in the literature. Moreover, our samples were not 
matched for age. Yet, as age was negatively correlated with 
ToM performance in the bipolar sample, we considered it 
unlikely that the result of patients performing similarly to 
controls on neurocognitive and ToM tasks should be due 
to their higher age. Taken together, the current study con-
trolled for a range of important variables and showed the 
importance of considering basic neurocognitive and clini-
cal variables when examining ToM abilities in BD. Future 
research should address the problems outlined above by 
developing ToM tasks that are difficult enough to produce 
sufficient variance and by examining larger samples.
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